中国癌症杂志 ›› 2022, Vol. 32 ›› Issue (5): 436-444.doi: 10.19401/j.cnki.1007-3639.2022.05.009

• 论著 • 上一篇    下一篇

T-G-C纳米材料联合声动力学治疗喉癌的研究

郑丹苹1()(), 钱炜1()(), 郑楚杰2   

  1. 1.江苏大学附属人民医院耳鼻咽喉科,江苏 镇江 212000
    2.南京中医药大学附属常州市中医院耳鼻咽喉科,江苏 常州 21300
  • 收稿日期:2022-02-14 修回日期:2022-05-03 出版日期:2022-05-30 发布日期:2022-06-09
  • 通信作者: 钱炜 E-mail:ncuzdp@163.com;dwqian@yahoo.com
  • 作者简介:郑丹苹(ORCID: 0000-0002-0215-8237),硕士在读 E-mail: ncuzdp@163.com

A study on T-G-C nanomaterials combined with sonodynamic therapy in the treatment of laryngeal cancer

ZHENG Danping1()(), QIAN Wei1()(), ZHENG Chujie2   

  1. 1. Department of Otolaryngology, the Affiliated People’s Hospital of Jiangsu University, Zhenjiang 212000, Jiangsu Province, China
    2. Department of Otolaryngology, the Affiliated to Nanjing University of Traditional Chinese Medicine, Changzhou Traditional Chinese Medicine Hospital, Changzhou 213000, Jiangsu Province, China
  • Received:2022-02-14 Revised:2022-05-03 Published:2022-05-30 Online:2022-06-09
  • Contact: QIAN Wei E-mail:ncuzdp@163.com;dwqian@yahoo.com

摘要:

背景与目的: 喉癌是目前难治性的耳鼻咽喉科恶性肿瘤,常采用放化疗联合手术治疗,但该疗法对患者的5年生存率和死亡率改善不大,且常伴随喉部功能丧失和药物抵抗。本研究旨在探索纳米声敏剂T-G-C颗粒介导的声动力学治疗(sonodynamic therapy,SDT)在抑制人喉癌细胞中的作用,为喉癌的治疗提供一种新型非侵入性的治疗方法。方法: 基于已经合成的T-G-C纳米材料,在激光扫描共聚焦显微镜下评价Tu686细胞摄取纳米材料的情况,在超声存在下用细胞计数试剂盒-8(cell counting kit-8,CCK-8)和Annexin Ⅴ-异硫氰酸荧光素(fluorescein isothiocyanate,FITC)试剂评估细胞存活和凋亡的情况。构建人喉癌细胞系Tu686的BALB/c裸小鼠移植瘤模型,通过注射不同类型药物和进行肿瘤区域超声辐照,在治疗期间记录小鼠体重和肿瘤变化,分析比较治疗效果;应用H-E、TUNEL、Ki-67及DHE染色等方法比较肿瘤细胞凋亡和活性氧(reactive oxygen species,ROS)产生情况。结果: 纳米材料与细胞温育24 h未见明显毒性,仅在超声刺激下导致细胞存活率下降,细胞主要以早期凋亡和晚期凋亡为主。动物实验中仅在第1、3、5和7天经过瘤内注射药物和超声处理,发现仅T-G-C+超声组小鼠肿瘤增长显著被抑制,抑瘤率为100%,且经16 d的治疗,肿瘤区域经超声辐照后可见明显的红色荧光,证实抑瘤作用的核心是ROS的产生。结论: 生物相容性高的T-G-C纳米颗粒在超声刺激时,激发了SDT和压电治疗的协同作用,通过ROS促进喉癌细胞早期和晚期凋亡,为喉癌提供了一种联合治疗方法,有望促进多学科治疗在耳鼻咽喉科中的应用。

关键词: 声动力学治疗, 喉癌, 纳米材料, 声敏剂, 活性氧

Abstract:

Background and purpose: Laryngeal cancer is a refractory malignant tumor in otolaryngology. Radiotherapy and chemotherapy combined with surgery are often used, however, this treatment method has little improvement on the 5-year survival rate and mortality of patients, and is often accompanied by loss of laryngeal function and drug resistance. This study aimed to explore the effect of sonodynamic therapy (SDT) mediated by nanoacoustic sensitizer T-G-C particles on inhibiting human laryngeal cancer cells, and to provide a new non-invasive treatment for laryngeal cancer. Methods: Based on the synthesized T-G-C nanomaterials, the uptake of nanomaterials by Tu686 cells was evaluated under confocal laser scanning microscope, and the cell survival and apoptosis were evaluated by cell counting kit-8 (CCK-8) and Annexin Ⅴ- fluorescein isothiocyanate (FITC) reagent in the presence of ultrasound. BALB/c nude mouse xenograft model was established. The weight and tumor changes of mice were recorded during the treatment by injecting different types of drugs and ultrasonic irradiation in the tumor area, and the treatment effects were analyzed and compared. The apoptosis and necrosis of tumor cells and the production of reactive oxygen species (ROS) were compared by H-E, TUNEL, Ki-67 and DHE stainings. Results: Nanomaterials and cells incubated for 24 hours had no obvious toxicity, only led to the decline of cell survival rate under ultrasonic stimulation, and the cells showed mainly early apoptosis and late apoptosis. In the animal experiment, only after intratumoral injection of drugs and ultrasound treatment on the 1st, 3rd, 5th and 7th days, the tumor growth of mice in T-G-C+ultrasound group was significantly inhibited, and the tumor inhibition rate is 100%. After 16 d of treatment, obvious red fluorescence could be seen in the tumor area after ultrasound irradiation, which demonstrated that the core of tumor inhibition was the production of ROS. Conclusion: Biocompatible T-G-C nanoparticles stimulate the synergy of SDT and piezoelectric therapy when stimulated by ultrasound, and promote the early and late apoptosis of laryngeal cancer cells through ROS, which provides a combined treatment method for laryngeal cancer and promotes the application of multidisciplinary therapy in department of otolaryngology.

Key words: Sonodynamic therapy, Laryngocarcinoma, Nanomaterials, Sonosensitizer, Reactive oxygen species

中图分类号: